Hologic Stock News

Abbott appears to have sold the entire 2020 run of the test to the U.S. government.

Rival Abbott is looking to become the dominant player in the coronavirus test arena.

The

Hologic (HOLX) has snapped up Acessa Health, a privately-held innovator in minimally invasive treatment for fibroids, for approximately $80 million in

Amalgamated Bank cut its stake in Hologic, Inc. (NASDAQ:HOLX) by 62.1% during the 2nd quarter, HoldingsChannel reports. The fund owned 16,445 shares of the medical equipment provider’s stock after s

The

Technically speaking, the S&P 500 and Nasdaq Composite have registered nominal record highs this week, though a pulling-teeth breakout attempt remains...

Calgary, Alberta--(Newsfile Corp. - August 18, 2020) -  Braveheart Resources Inc. (TSXV: BHT) (OTCQB: RIINF) ("Braveheart" or the "Company") is pleased to announce that it has entered into a letter o

I bought Hologic during the March sell-off because the future return prospects looked promising if market conditions reverted to the mean over the long term.

InMode went public in August, 2019, raising $70 million. The firm sells medical aesthetic technologies in the U.S.

Calgary, Alberta--(Newsfile Corp. - August 14, 2020) - Braveheart Resources Inc. (TSXV: BHT) (OTCQB: RIINF) ("Braveheart" or the "Company") hereby announces that it has reduced its debt by $2.4 millio

Investors seem to be impressed with National Vision's (EYE) better-than-expected second-quarter 2020 results despite the coronavirus-led economic crisis.

Technically speaking, the U.S. benchmarks’ already-bullish backdrop has strengthened amid rotational August price action, writes Michael Ashbaugh.

Syneos Health (SYNH) wins 35 COVID-19 related projects through the second quarter.

Hologic Launches Validated Pooling Protocol for COVID-19 Testing | STL.News | Read business news and more at STL.News.